Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies

<p><strong>Background</strong><br> Our understanding of the global scale of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection remains incomplete: Routine surveillance data underestimate infection and cannot infer on population immunity; there is a predomi...

Full description

Bibliographic Details
Main Authors:	Bergeri, I, Whelan, MG, Ware, H, Subissi, L, Nardone, A, Lewis, HC, Li, Z, Ma, X, Valenciano, M, Cheng, B, Al Ariqi, L, Rashidian, A, Okeibunor, J, Azim, T, Wijesinghe, P, Le, L-V, Vaughan, A, Pebody, R, Vicari, A, Yan, T, Yanes-Lane, M, Cao, C, Clifton, DA, Cheng, MP, Papenburg, J, Buckeridge, D, Bobrovitz, N, Arora, RK, Van Kerkhove, MD
Other Authors:	Unity Studies Collaborator Group
Format:	Journal article
Language:	English
Published:	Public Library of Science 2022
Subjects:	Metaanalysis SARS CoV 2 Medical risk factors Virus testing COVID 19 Vaccination and immunization Respiratory infections Low and middle income countries

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies

Similar Items